Joseph McLaughlin - Concepedia

Concepedia

Author

Joseph McLaughlin

Yale University

Also Known As

Joseph F. McLaughlin, Joseph Francis McLaughlin, Joseph McLaughlin

19

Publications

1.8K

Citations

10

H-Index

23

Concepts

All Affiliations

Yale University Yale Cancer Center Cleveland Clinic Smilow Cancer Hospital

JM

About

Joseph McLaughlin is an author at Yale University specializing in cancer research, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	232
2	Pathology	5	5	232
3	Immunology	4	4	67
4	Cell Biology	2	2	181
5	Pharmacology	1	1	15

Joseph McLaughlin

×

11

Publications

1.8K

Citations

10

H-Index

	Year	Citations
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer Joseph McLaughlin, Gang Han, Kurt A. Schalper, JAMA Oncology	2015	828
Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer Kurt A. Schalper, Jason R. Brown, Daniel Carvajal‐Hausdorf, JNCI Journal of the National Cancer Institute	2015	428
Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Joseph McLaughlin, Clinical Cancer Research	2016	204
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer Jamaal Rehman, Gang Han, Daniel Carvajal‐Hausdorf, Modern Pathology Tumor MicroenvironmentPathologist-read ComparisonMedicinePathologyCell Death	2016	165
High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program Joseph McLaughlin, Samir K. Ballas Transfusion	2015	32
Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Joseph McLaughlin, Journal for ImmunoTherapy of Cancer Tumor-associated MacrophagesCancer ImmunosurveillanceTumor MicroenvironmentLung InflammationPd-1/pd-l1 Axis	2015	26
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma Maria Toki, Daniel Carvajal‐Hausdorf, Mehmet Altan, Journal of Thoracic Oncology	2016	17
Domain-specific PD-L1 protein measurement in non-small cell lung cancer (NSCLC). Joseph McLaughlin, Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Journal of Clinical Oncology ImmunologyPathologyNsclc SamplesImmunotherapyCancer Biology	2014	16
Safety, pharmacokinetics (PK), pharmacodynamics (Pd), and antitumor activity in a phase 1b study evaluating anti-ErbB3 antibody KTN3379 in adults with advanced tumors alone and with targeted therapies. Gerald S. Falchook, Todd M. Bauer, Patricia LoRusso, Journal of Clinical Oncology Anti-erbb3 Antibody Ktn3379ImmunologyPathologyHuman Anti-erbb3 AntibodyImmunotherapeutics	2016	15
Scale‐dependent manganese leaching from stainless steel impacts terminal galactosylation in monoclonal antibodies Jenna Williamson, Jennifer Miller, Joseph McLaughlin, Biotechnology Progress	2018	12

Page 1